Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01622530 · ClinicalTrials.gov registry record

Development of a Simulation Tool for Upper Extremity Prostheses

A clinical trial of Traumatic Amputation of Upper Limb, Level Unspecified, sponsored by University of South Florida.

Completed
Registry status
30
Enrollment target
1
Study location

NCT01622530 is a study of Traumatic Amputation of Upper Limb, Level Unspecified that has completed, run by University of South Florida. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01622530, a study of Traumatic Amputation of Upper Limb, Level Unspecified, has completed, sponsored by University of South Florida.

COMPLETED
Registry status
30 participants
Enrollment target
1
Study location

Study Summary

Amputees often choose not to wear prostheses due to marginal performance or may settle for a prosthesis that offers only cosmetic improvement, but lacks function. A simulation tool consisting of a robotics-based human body model (RHBM) to predict functional motions, and integrated modules for aid in prescription, training, comparative study, and determination of design parameters of upper extremity prostheses will be developed. The main objective of collecting and analyzing human movement during several common tasks is to optimize and validate the robotics based human model. The range of motion data of subjects performing activities of daily living such as opening a door, turning a wheel, grooming, eating, bilateral lifting, as well as recreational and sport activities such as swinging a baseball bat, and golf club will be analyzed. This motion analysis data will also be used to compare data between four groups: a control group (n=10), a braced group simulating prosthesis use (n=10), a group wearing a transradial prosthesis (n=10) and a group wearing a transhumeral prosthesis (n =10).

Study Locations (1)

Florida

  • University of South Floria RRT building - Tampa

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2010-07
Est. Completion 2017-12

Sponsor

University of South Florida

252 total trials

What the Registry Record Tells You About NCT01622530

The ClinicalTrials.gov registry entry for NCT01622530 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Traumatic Amputation of Upper Limb, Level Unspecified appearing as the primary indexed condition, and to 0 interventions.

NCT01622530 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT01622530 about?

NCT01622530 is a clinical study titled "Development of a Simulation Tool for Upper Extremity Prostheses". Amputees often choose not to wear prostheses due to marginal performance or may settle for a prosthesis that offers only cosmetic improvement, but lacks function. A simulation tool consisting of a robotics-based human body model (RHBM) to predict functional motions, and integrated modules for aid in...

What is the current status of trial NCT01622530?

This trial is currently completed. The enrollment target is 30 participants. The study started on 2010-07. Estimated completion is 2017-12.

What conditions does trial NCT01622530 study?

This clinical trial studies the following conditions: Traumatic Amputation of Upper Limb, Level Unspecified.

Who is sponsoring clinical trial NCT01622530?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01622530 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.